Arrow Diagnostics

Today marks Seegene's 24th anniversary! 🎉 Over the past 24 years, your trust and support have enabled us to grow as a global leader in molecular diagnostics. We remain committed to pioneering innovative technologies that advance healthcare worldwide and create a brighter future. Thank you for your unwavering support, and we look forward to continuing this journey with you! #Seegene #24thAnniversary #AWorldFreefromDiseases

Join #Seegene at the 13th #EMMD, happening from October 9 to 11, in Noordwijk, Netherlands. Visit booth #9 to discuss how Seegene is advancing molecular technologies and transforming healthcare diagnostics. We look forward to connecting with you in Noordwijk and exploring the exciting possibilities in molecular diagnostics! #MolecularDiagnostics #EMMD2024 #EuropeanMeetingOnMolecularDiagnostics

🌐 Breaking new ground in precision oncology research and care to be announced at #ESMO2024! SOPHiA GENETICS is thrilled to announce that several world-renowned healthcare organizations have joined SOPHiA UNITY, the global collective intelligence network we launched to revolutionize oncology research and care. SOPHiA UNITY connects top healthcare institutions to leverage multimodal data and real-world insights, accelerating advancements in cancer diagnostics and research. Collaborations made possible by SOPHiA UNITY pave the way for continued advancement of oncology research and data-driven medicine.  World-class institutions like Exactis Innovation in Canada and Institut Paoli-Calmettes in France are now part of this growing global network, joining inaugural member Memorial Sloan Kettering Cancer Center. Also, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, named the best hospital in Italy in 2024, has expressed interest in joining the collaborative. Together, we’re harnessing the power of high-quality, diverse data from over 100,000 patient profiles to drive innovation and improve patient outcomes. "By uniting a critical mass of data and expertise through SOPHiA UNITY, we are empowering a global network of top-tier institutions to tackle the complexities of cancer. This initiative provides a new opportunity to advance oncology research with one of the most robust sources of diverse data available in the market to drive breakthroughs and improve patient outcomes worldwide," said Jurgi Camblong, PhD, Co-founder and CEO of SOPHiA GENETICS. "Together, we have the power to change the world." Read more about how SOPHiA UNITY is transforming the future of precision oncology: https://loom.ly/mpEXr8k #PrecisionOncology #OncologyResearch #DataDrivenMedicine #AIforHealthcare

We're excited to attend in DGTI 2024 exhibition in Düsseldorf, Germany, from September 11th to 13th! ⠀ Find us at Booth No. 11 and meet our outstanding products Join us for an unforgettable experience at #DGTI2024! ⠀ #NanoEntek #IVD #DGTI #Bloodtransfusion #나노엔텍

🚀 We’re excited to announce that SOPHiA GENETICS has joined the prestigious European Liquid Biopsy Society (ELBS), a network of over 87 academic and industry leaders working towards making liquid biopsy tests part of routine care. This news is being shared at the ECP 2024 event, where our team will be highlighting the importance of liquid biopsy in oncology research and tumor mutation profiling. Our collaboration with partners like Memorial Sloan Kettering Cancer Center (MSK) and institutions across Europe has helped make best-in-class liquid biopsy solutions accessible to patients worldwide. Learn more about this exciting partnership and our work to advance liquid biopsy as a standard of care: https://loom.ly/9qKPN78 #LiquidBiopsy #HealthcareInnovation #ECP2024 #DataDrivenMedicine #Partnerships

🧠 September is Alzheimer’s Awareness Month, and recent research from Baylor College of Medicine reveals new insights into the connection between brain fungal infections and Alzheimer’s disease. This study, published in Cell Reports, specifically highlights how *Candida albicans* enter the brain and generate amyloid beta (Ab)-like peptides linked to Alzheimer's development. Previous studies have suggested a role for fungi in chronic neurodegenerative conditions, but this research provides a clearer understanding of how C. albicans contributes to these diseases. Researchers discovered that C. albicans uses enzymes to breach the blood-brain barrier and produce Ab-like peptides, potentially influencing Alzheimer's pathology. Our FungiXpert CLIA Candida detection kits for Candida, including Candida albicans, are designed to support early detection and management of such infections. These advanced diagnostic tools can help identify C. albicans in the brain and assist in exploring its role in neurodegenerative conditions. Learn more about the study and its implications for Alzheimer's research: https://lnkd.in/e8XsPeWz. #AlzheimersAwarenessMonth #FungalInfections #CandidaAlbicans #HealthcareInnovation #EarlyDetection #Erabiology #CLIA #FungiXpert

🎗️ September marks #OvarianCancerAwarenessMonth. At SOPHiA GENETICS, we are proud to join organizations worldwide in raising awareness for this critical cause! Beyond being a tech company, we’re a team driven by a shared mission to make a meaningful impact in #healthcare. 💙 Our hearts beat with the mission to create real, positive change for those affected by ovarian cancer. This month, we stand with the global community to amplify the message of urgency and awareness. Join us in spreading knowledge, compassion, and hope. Together, we can make a difference. 📍 Learn more about the impact of HRD (Homologous Recombination Deficiency) on ovarian cancer development: https://loom.ly/SbmK5gw #TealforAwareness #OvarianCancer #OvarianCancerAwareness #HRD